OmniCyte Founder, Peter Leonardi, provides insight into the emerging field of immunotherapy. Immunotherapy is the…
Threshold Pharmaceuticals takes advantage of the differences in metabolic activity between cancerous and normal, healthy biological tissue.
The Aliso Viejo, Calif.-based company achieved several major milestones in 2009.
The Nasdaq rose 5 points on Monday, due in part to recent happenings in the biopharmaceutical sector.